|
Clinical feature
|
Total
|
SOX30 expression
|
P value
|
|---|
|
High (n = 94)
|
Low (n = 181)
|
|---|
|
Age (years)
|
|
≤ 60
|
151
|
56
|
95
|
0.328
|
|
> 60
|
121
|
38
|
83
| |
|
Clinical stage
|
|
I
|
116
|
42
|
74
|
0.023
|
|
II
|
39
|
14
|
25
| |
|
III
|
56
|
13
|
43
| |
|
IV
|
16
|
1
|
15
| |
|
Tumor size
|
|
T1–2
|
213
|
76
|
137
|
0.012
|
|
T3–4
|
31
|
4
|
27
| |
|
Lymph node status
|
|
N0
|
128
|
45
|
83
|
0.160
|
|
N1–3
|
95
|
25
|
70
| |
|
Metastasis
|
|
M0
|
230
|
78
|
152
|
0.022
|
|
M1
|
16
|
1
|
15
| |
|
Gender
|
|
Male
|
152
|
52
|
100
|
0.991
|
|
Female
|
123
|
42
|
81
| |
|
Histological grade
|
|
1
|
28
|
7
|
21
|
0.486
|
|
2
|
108
|
40
|
68
| |
|
3
|
70
|
25
|
45
| |
|
Tumor diameter
|
|
≤ 4 cm
|
196
|
72
|
124
|
0.082
|
|
> 4 cm
|
71
|
18
|
53
| |
|
Location
|
|
Left
|
125
|
46
|
79
|
0.426
|
|
Right
|
149
|
48
|
101
| |
- The p values were measured with Pearson chi-square tests
- The tumor clinical stage, tumor status, lymph node status and metastasis were classified according to the international system
- All statistical tests are two sided
- The entries in boldface indicate statistically significant
